Doctor Ana Filipa Fonseca
Novartis Sweden AB, Stockholm (Sweden)
Concordance between patient and physician reported symptoms in patients with heart failure and a LVEF equal to or less than 60%: a multinational survey in the EU
Event: ESC Congress 2020
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic Heart Failure ePosters
A real-world assessment of the distribution of lipid levels across increasing lipoprotein(a) levels in patients with established cardiovascular disease in the United States
Event: ESC Congress 2020
Topic: Lipids
Session: Risk Factors and Prevention ePosters
